BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 26462893)

  • 1. [Estimation of venous thromboembolism risk with thrombotic biomarkers in cancer patients].
    Jianlong M; Diansheng Z; Jing R
    Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):283-9. PubMed ID: 26462893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer.
    Pépin M; Kleinjan A; Hajage D; Büller HR; Di Nisio M; Kamphuisen PW; Salomon L; Veyradier A; Stepanian A; Mahé I
    J Thromb Haemost; 2016 Feb; 14(2):306-15. PubMed ID: 26589836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
    Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
    J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Predictive value of von Willebrand factor for venous thromboembolism in critically ill patients based on propensity score matching].
    Yue J; Wan L; Wang G; Zhang R; Zhang X; Liu O; Yu X; Huang Q; Ren Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Jan; 36(1):73-77. PubMed ID: 38404276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and Prognostic Value of TAT, PIC, TM, and t-PAIC in Malignant Tumor Patients With Venous Thrombosis.
    Zhou K; Zhang J; Zheng ZR; Zhou YZ; Zhou X; Wang LD; Suo B; Jiang XF; Liu PJ; Wang DH
    Clin Appl Thromb Hemost; 2020; 26():1076029620971041. PubMed ID: 33141604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usefulness of D-dimer in diagnosis and prediction of venous thromboembolism in patients with abdominal malignancy.
    Kwietniak M; Al-Amawi T; Błaszkowski T; Sulżyc-Bielicka V; Kładny J
    Pol Przegl Chir; 2017 Jun; 89(3):27-30. PubMed ID: 28703112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications.
    Voicu S; Delrue M; Chousterman BG; Stépanian A; Bonnin P; Malissin I; Deye N; Neuwirth M; Ketfi C; Mebazaa A; Siguret V; Mégarbane B
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):9161-9168. PubMed ID: 32965009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Prognostic Significance of Coagulation Assays in Pancreatic Cancer Patients With Absence of Venous Thromboembolism.
    Sun W; Ren H; Gao CT; Ma WD; Luo L; Liu Y; Jin P; Hao JH
    Am J Clin Oncol; 2015 Dec; 38(6):550-6. PubMed ID: 24401666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal analysis of hemostasis biomarkers in cancer patients during antitumor treatment.
    Reitter EM; Kaider A; Ay C; Quehenberger P; Marosi C; Zielinski C; Pabinger I
    J Thromb Haemost; 2016 Feb; 14(2):294-305. PubMed ID: 26662117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-dimer, factor VIII and von Willebrand factor predict a non-dipping pattern of blood pressure in hypertensive patients.
    Agorasti A; Trivellas T; Mourvati E; Papadopoulos V; Tsatalas K; Vargemezis V; Passadakis P
    Int Urol Nephrol; 2013 Jun; 45(3):777-83. PubMed ID: 23001640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel high-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in intermediate risk lung cancer patients.
    Ferroni P; Martini F; Portarena I; Massimiani G; Riondino S; La Farina F; Mariotti S; Guadagni F; Roselli M
    Clin Lung Cancer; 2012 Nov; 13(6):482-7. PubMed ID: 22591606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can an age-adjusted D-dimer level be adopted in managing venous thromboembolism in the emergency department? A retrospective cohort study.
    Jaconelli T; Eragat M; Crane S
    Eur J Emerg Med; 2018 Aug; 25(4):288-294. PubMed ID: 28079562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumour cells are linked to plasma D-dimer levels in patients with metastatic breast cancer.
    Mego M; Zuo Z; Gao H; Cohen EN; Giordano A; Tin S; Anfossi S; Jackson S; Woodward W; Ueno NT; Valero V; Alvarez RH; Hortobagyi GN; Khoury JD; Cristofanilli M; Reuben JM
    Thromb Haemost; 2015 Mar; 113(3):593-8. PubMed ID: 25373787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative D-dimer predicts venous thromboembolism in patients undergoing urologic tumor surgery.
    Shi A; Huang J; Wang X; Li M; Zhang J; Chen Y; Huang Y
    Urol Oncol; 2018 Jun; 36(6):307.e15-307.e21. PubMed ID: 29599070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combination of Caprini risk assessment scale and thrombotic biomarkers to evaluate the risk of venous thromboembolism in critically ill patients.
    Fu Y; Liu Y; Chen S; Jin Y; Jiang H
    Medicine (Baltimore); 2018 Nov; 97(47):e13232. PubMed ID: 30461624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk factors of lung cancer complicated with symptomatic venous thromboembolism].
    Gong CY; Li ZW; Zhou DX; Yan H; Bao J; Ye RJ; Cao ZL; Gao ZC; Mu XL
    Zhonghua Jie He He Hu Xi Za Zhi; 2016 Jun; 39(6):454-8. PubMed ID: 27289575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.
    Dujardin RWG; Hilderink BN; Haksteen WE; Middeldorp S; Vlaar APJ; Thachil J; Müller MCA; Juffermans NP
    Thromb Res; 2020 Dec; 196():308-312. PubMed ID: 32977128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of C-Reactive Protein, Procalcitonin, TAT Complex, and Factor VIII in Addition to D-Dimer in the Exclusion of Venous Thromboembolism in Primary Care Patients.
    Heerink JS; Gemen E; Oudega R; Geersing GJ; Hopstaken R; Kusters R
    J Appl Lab Med; 2022 Mar; 7(2):444-455. PubMed ID: 34597379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer.
    Moik F; Prager G; Thaler J; Posch F; Wiedemann S; Schramm T; Englisch C; Mackman N; Pabinger I; Ay C
    Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2837-2847. PubMed ID: 34470475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application value of Caprini risk assessment model and elevated tumor-specific D-dimer level in predicting postoperative venous thromboembolism for patients undergoing surgery of gynecologic malignancies.
    Shi J; Ye J; Zhuang X; Cheng X; Fu R; Zhao A
    J Obstet Gynaecol Res; 2019 Mar; 45(3):657-664. PubMed ID: 30393982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.